As with any new technology, it takes baby steps to get drugs through the regulatory process and onto the market. And nanomedince is no exception. The technology is certainly progressing, but at a methodical pace. Read More
The general markets have not exactly been on a roll since the beginning of the year, with the Dow Jones Industrial Average recording just a 1.6 percent gain and the Nasdaq Composite index posting a 5.7 percent jump in value. Despite that lukewarm performance, it hasn't put a damper on the red hot biotech sector, which continues its steady upward climb. Read More
